13F filer · CIK 1969764
Propel Bio Management, LLC
Los Angeles, CA · filing since Q4 2023 · last filing Aug 13, 2026
Reported value
$191.1M
+$32.4M vs prior
Positions
29
New / sold out
4 / 13
Added / reduced
11 / 10
Turnover
20.1%
buys $35.1M · sells $39.4M
Top-10 weight
68.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ARTIVA BIOTHERAPEUTICS IN | +550,067 | +375.8% | +$5.3M |
| New | IMMUNIC INC | +325,022 | – | +$5.0M |
| Added | MILESTONE PHARMACEUTICALS | +3,311,269 | +80.4% | +$4.4M |
| Added | PALISADE BIO INC | +1,467,388 | +131.6% | +$3.1M |
| Added | AQUESTIVE THERAPEUTICS IN | +731,409 | +102.9% | +$3.0M |
| Added | PHATHOM PHARMACEUTICALS I | +209,086 | +24.9% | +$2.3M |
| New | SCYNEXIS INC | +543,478 | – | +$2.2M |
| Added | KYVERNA THERAPEUTICS INC | +238,777 | +37.1% | +$2.1M |
| New | SILENCE THERAPEUTICS PLC | +191,733 | – | +$2.1M |
| Added | INVENTIVA SA - ADR | +556,534 | +76.8% | +$2.1M |
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | VOR BIOPHARMA INC | -314,543 | -100.0% | $-5.6M |
| Sold out | VIRIDIAN THERAPEUTICS INC | -210,163 | -100.0% | $-4.1M |
| Sold out | OCULIS HOLDING AG | -122,223 | -100.0% | $-3.3M |
| Sold out | TREVI THERAPEUTICS INC | -223,802 | -100.0% | $-2.6M |
| Sold out | IMMUNIC INC | -2,344,779 | -100.0% | $-2.6M |
| Sold out | COHERUS ONCOLOGY INC | -1,420,550 | -100.0% | $-2.4M |
| Reduced | COMPASS PATHWAYS PLC | -168,963 | -22.8% | $-2.4M |
| Reduced | ABEONA THERAPEUTICS INC | -346,829 | -26.1% | $-2.1M |
| Sold out | KALARIS THERAPEUTICS INC | -295,771 | -100.0% | $-1.7M |
| Sold out | UNIQURE NV | -104,772 | -100.0% | $-1.7M |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PLAINS GP HOLDINGS LP-CLCOMM | 1,272,360 | $30.9M | 16.16% |
| 2 | ACHIEVE LIFE SCIENCES INCCOMM | 4,034,018 | $26.3M | 13.79% |
| 3 | CORCEPT THERAPEUTICS INCCOMM | 136,499 | $11.9M | 6.21% |
| 4 | PHATHOM PHARMACEUTICALS ICOMM | 1,050,358 | $11.4M | 5.96% |
| 5 | DELCATH SYSTEMS INCCOMM | 871,460 | $11.0M | 5.74% |
| 6 | MILESTONE PHARMACEUTICALSCOMM | 7,429,590 | $10.0M | 5.21% |
| 7 | COMPASS PATHWAYS PLCADRS | 573,086 | $8.1M | 4.24% |
| 8 | KYVERNA THERAPEUTICS INCCOMM | 883,198 | $7.9M | 4.12% |
| 9 | ARTIVA BIOTHERAPEUTICS INCOMM | 696,436 | $6.8M | 3.54% |
| 10 | ABEONA THERAPEUTICS INCCOMM | 983,070 | $6.1M | 3.18% |
19 more rows. Subscribe for $29/month to see every row, download the data and use the API.